KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Accumulated Expenses (2023 - 2025)

Astrana Health (ASTH) has disclosed Accumulated Expenses for 4 consecutive years, with $31.6 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 41.08% to $31.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.6 million through Dec 2025, up 41.08% year-over-year, with the annual reading at $31.6 million for FY2025, 41.08% up from the prior year.
  • Accumulated Expenses hit $31.6 million in Q4 2025 for Astrana Health, up from $30.1 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $31.6 million in Q4 2025 to a low of $13.8 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged $21.5 million across 3 years, with a median of $20.2 million in 2023.
  • Biggest five-year swings in Accumulated Expenses: increased 11.5% in 2024 and later soared 72.01% in 2025.
  • Year by year, Accumulated Expenses stood at $20.1 million in 2023, then grew by 11.5% to $22.4 million in 2024, then surged by 41.08% to $31.6 million in 2025.
  • Business Quant data shows Accumulated Expenses for ASTH at $31.6 million in Q4 2025, $30.1 million in Q3 2025, and $20.2 million in Q2 2025.